Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
about
Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.Cognitive decline in Parkinson disease.Impact of multiple pathologies on the threshold for clinically overt dementia.Interactions of pathological proteins in neurodegenerative diseases.Lewy Body Disorders.Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias.Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's caseImaging of glia activation in people with primary lateral sclerosis.Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.Flortaucipir tau PET imaging in semantic variant primary progressive aphasia.cGMP production of the radiopharmaceutical [18 F]MK-6240 for PET imaging of human neurofibrillary tangles.Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia.Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography.Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia.CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies.The development and validation of tau PET tracers: current status and future directionsAssessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography ImagingCan neuroimaging predict dementia in Parkinson's disease?
P2860
Q33754677-0998FA7F-6814-4F06-B163-BE6379B56E8DQ37633577-61398013-C331-4A5B-862F-30089FF5D833Q38642389-797541C0-ADE4-4A7E-86BE-079A8845BAF0Q38751099-18B2F3D1-46E0-42C8-938D-E38ABF25C0D5Q38794960-3BF5F065-D0FD-4B64-971F-9C13971BBD28Q39236779-89713CA3-A85A-4DC9-BE9D-08E483C2452DQ39243369-E7B76B39-84F5-4F17-A398-A687418793C9Q39346750-F8BCA78F-770E-4816-88B8-B27223201C4FQ41163005-B0607265-46E8-445A-994F-741C0AAF62E2Q42672461-C8FBE8DB-B9F9-48B8-97C1-54D5F21B65BAQ44728742-87B89D63-75F6-4F2E-A8E8-4260DFA929FCQ45974423-50F7AE1E-E829-4804-8674-6945830DE769Q46012657-4A79CF2D-74D7-4E2E-B452-26C1F8AAF962Q47684719-A64CEC56-02F9-4957-84BD-D3F5BC80AE5FQ48254051-88C6B4CE-9467-4DFE-ABAB-4AB9B8076F99Q48267581-EFE4532B-427C-4988-B267-81279525C854Q48550610-172BE032-239A-460B-A4A7-4107DD3EE085Q48687926-F92C06C8-30BA-4DFF-9827-167D6B061E4DQ49295547-E02E5CC3-BB64-4401-9860-D0D954CCF216Q49987358-C76FB198-1629-4158-A30A-D309EBFD25DAQ50042841-0B8CB80A-A5EF-4E8D-9AE5-B6F9A215CD8FQ51766645-2B65E15E-64F7-4628-A6E4-D2D344447716Q53512229-AD7D92BA-5269-4B8B-9EDF-9AA29AF821AEQ54982491-A4597988-C689-4BE4-AA66-89EE608D6681Q55359027-A205D7B4-7C76-4671-ADCC-EBF523186967Q56594907-82A2D214-F78A-4B39-B4B1-D6DC4A17C701Q57214180-274018AD-21D8-4E18-824C-E489A6FEB4EFQ58696822-FF49CC1E-DCB2-45B5-8F29-5329F3F5796F
P2860
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
@en
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
@nl
type
label
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
@en
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
@nl
prefLabel
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
@en
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
@nl
P2093
P2860
P1433
P1476
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
@en
P2093
Aaron Schultz
Bradford C Dickerson
Christina Caso
John H Growdon
Joseph J Locascio
Keith Johnson
Neil Vasdev
Sara J Makaretz
Stephen N Gomperts
P2860
P304
P356
10.1001/JAMANEUROL.2016.3338
P407
P577
2016-09-19T00:00:00Z